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Background/aim: To evaluate the prevalence of tetanus vaccination in pregnant women and determine the factors affecting the
vaccination and barriers to vaccination.
Materials and methods: An observational-descriptive study was conducted on 494 women who gave birth at the Etlik Zübeyde Hanım
Women’s Health Training and Research Hospital, Ankara, Turkey. Participants were divided into 2 groups, vaccinated and unvaccinated.
Sociodemographic characteristics, obstetric history, and prenatal care status were compared between the 2 groups.
Results: There were 242 (48.9%) and 252 (51.1%) women in the vaccinated and unvaccinated groups, respectively. The vaccination
rate decreased as the number of pregnancies increased (P = 0.009). As the level of income increased, there was a statistically significant
increase in the vaccination rate (P = 0.048). The status of education and having an occupation did not affect the vaccination rate (P >
0.05). The vaccination rate was higher in women with regular follow-ups when compared to those who did not get a regular follow-up
(76.5% vs. 38.7%) (P = 0.001). The vaccination rate was significantly higher in women who had knowledge about tetanus vaccine during
pregnancy (P < 0.005).
Conclusions: All pregnant women should be encouraged to get regular antenatal care to increase vaccination rates. Health care providers
should give all pregnant women detailed information about the safety, effectivity, and benefits of vaccines.
Key words: Maternal tetanus, tetanus vaccine, pregnancy

1. Introduction
Tetanus is caused by contamination of Clostridium tetani
spores into wounds after the disruption of skin integrity
and mucous membranes [1]. Tetanus that occurs in
women during pregnancy or within 6 weeks after delivery
is defined as maternal tetanus (MT). Neonatal tetanus
(NT) is a disease that occurs in newborns due to childbirth
under poor hygiene conditions. NT is an important cause
of perinatal morbidity and mortality. NT is common in
developing countries where maternal immunization is
insufficient, especially when delivery is not performed
under sterile conditions. Up to 100% of untreated cases
result in death [2].
Tetanus is a disease that can be prevented by vaccines
containing tetanus-toxoids. Antibodies produced by
maternal immunization that pass to the fetus via the

placenta protect the baby in terms of tetanus during the
neonatal period [2]. Elimination of maternal NT (MNT)
has been defined as less than 1 NT case per 1000 live births
in a specific region by the World Health Organization
(WHO). MNT elimination strategies include vaccination,
hygienic practices at delivery, and surveillance1.
The WHO recommends combination vaccines,
including tetanus toxoid and diphtheria toxoid (Td),
for immunization against tetanus2. The first dose is
recommended at the first prenatal visit and the second
dose is recommended 4 weeks following that for pregnant
women whose vaccination status is unknown or those who
have not previously been vaccinated. Vaccine doses should
be completed at least 2 weeks prior to delivery to ensure
adequate protection after the second dose of the vaccine.
At least 6 months after the second dose, the third dose
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should be completed and then, 1 additional dose should
be administered with 1-year interval3.
According to the 2018 WHO data, the Td vaccination
rate of 2 doses in pregnant women was 72% worldwide, and
this rate was about 55% in Turkey4. It is recommended that
at least 80% of pregnant women should be fully vaccinated
against tetanus to achieve and maintain MNT elimination
[3]. Td vaccination rates differ among countries such as
Thailand 96%, Malaysia 93%, Tunisia 90%, Viet Nam 88%,
Spain 84%, and India 81%, where vaccination rates are
high and MNT elimination has been achieved5.
In this study, it was aimed to evaluate the prevalence
of tetanus vaccination in pregnant women who gave birth
at the Etlik Zübeyde Hanım Women’s Health Training and
Research Hospital, in Ankara, Turkey. Also investigated
were the factors affecting vaccination and barriers to
vaccination, to understand future needs towards increasing
vaccination rates.
2. Materials and methods
An observational-descriptive study was conducted with
494 women who gave birth at the Etlik Zübeyde Hanım
Women’s Health Training and Research Hospital, in
Ankara, Turkey, between January 1, 2019 and January
31, 2019. Signed informed consent was obtained from
participants who agreed to be involved in the study. The
study protocol was approved by the Ethical Committee of
the University of Health Sciences Turkey, Etlik Zübeyde
Hanim Women’s Health Training and Research Hospital
(02.01.2019-29/1), and complied with the Helsinki
Declaration.
A data collection form related to tetanus vaccine was
applied via face-to-face interviews by the same investigator
(GD). The women were asked various questions regarding
their age, number of pregnancies, monthly income,
frequency of antenatal care, and whether they had
vaccination in this pregnancy. The main refusal reasons
were also requested from the women who had not been
vaccinated during pregnancy.
In terms of vaccination, the participants were divided
into 2 groups, vaccinated and unvaccinated. Women
who had received 2 doses of vaccine during their current
pregnancy were accepted as fully vaccinated. In addition,
women who stated that they had received 2 doses of
vaccine in their previous pregnancies and who received a
single dose of vaccine in the current pregnancy were also
considered to be fully vaccinated. The remaining women

were classified as unvaccinated. Sociodemographic
characteristics, obstetric history, and prenatal care status
were compared between the 2 groups. Factors affecting the
decisions of women who did not receive the vaccine were
also analyzed.
Data were analyzed using descriptive statistics, such as
the mean, standard deviation, and frequency using IBM
SPSS Statistics for Windows 23.0 (IBM Corp., Armonk,
NY, USA). Variables in the groups were evaluated using the
Shapiro–Wilk test for distribution. Normal distributions
were evaluated using parametric tests (independent t test)
and those without normal distribution were evaluated
using nonparametric tests (Mann–Whitney U test).
The chi square test was used to evaluate the categorical
variables.
3. Results
Among the 494 women who participated in the study,
74.1% (n = 366) stated that they had been vaccinated in
their last pregnancy and the remaining 25.9% (n = 128)
said they had never been vaccinated. Of the women who
received the vaccine, 45.3% (n = 224) had been vaccinated
with 2 doses and 28.7% (n = 142) had been vaccinated
only with a single dose. Among the women who received
a single dose of vaccine, 18 were considered to be fully
vaccinated because they had received 2 doses of vaccine
in their previous pregnancies. As a result, the rate of
vaccinated and unvaccinated women was 48.9% (n = 242)
and 51.1% (252), respectively. The Figure shows the groups
in detail.
Table 1 shows the comparison of the demographic and
socioeconomic characteristics of the women between the
2 groups. The vaccination rate was 82.1% and 64% in the
nulliparous and multiparous women, respectively. The
vaccination rate decreased as the number of pregnancies
increased (P = 0.009). As the level of income increased,
there was a statistically significant increase in the
vaccination rate (P = 0.048). The status of education and
having an occupation did not affect the vaccination rate
(P > 0.05). As shown in Table 2, it was observed that
antenatal follow-up frequency had an impact on the rates
of vaccination. The vaccination rate was higher in women
with regular follow-ups when compared to those who did
not get a regular follow-up (76.5% vs. 38.7%) (P = 0.001).
The total number of women who stated that they
were informed about Td vaccine during pregnancy was
340 (68.8%), and the rate of vaccination in this group
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Figure. Flowchart of the study.

was 89.7%. Moreover, 212 (62.3%) of the women were
informed by doctors, 123 (35.8%) by midwives/nurses,
and the remaining 6 (1.9%) via media/internet. The
vaccination rate was significantly higher in women who
had knowledge about tetanus vaccine during pregnancy
than in those who did not know about the vaccine (P <
0.005).
Table 3 shows the detailed data of the unvaccinated
women. Of the 128 women who were unvaccinated, 46.8%
(n = 60) stated they did not know that they should have
been vaccinated, 12.5% (n = 16) thought that the vaccine
was not useful, and 11.7% (n = 15) said that they did not
know where or when to get the vaccine. Moreover, 10.9%
(n = 14) had not been vaccinated because they had been
vaccinated during their previous pregnancy.
4. Discussion
Tetanus occurs as a result of the contamination of
wounds with Clostridium tetani spores in women without
protective antibodies. It is not possible to eradicate the
disease because these spores are widespread in the soil
and feces of animals. Therefore, it is important to ensure

surveillance by recommended vaccination programs6.
Immunization with tetanus vaccine during pregnancy
is an effective method to protect the newborn against
disease. Tetanus vaccines are available as toxoid alone
(TT), with diphtheria toxoid (Td), or in combination with
diphtheria and pertusis vaccines (Tdap). A single dose of
Tdap vaccine is recommended for pregnant women in the
USA within 27–36 weeks of gestation in every pregnancy
[4]. The WHO recommends using Td for immunization
against tetanus [3]. In Turkey, Td vaccine began to be
used instead of TT vaccine after August 2004 as a result
of the recommendation of the Ministry of Health with the
decision of the Immunization Advisory Board7. According
to the WHO MNT elimination strategies, it has also been
aimed in Turkey to reduce the number of NT cases in each
region to <1 in 1000 live births and ensure that MT is
eliminated. Hence, tetanus vaccines are administered free
of charge to all pregnant women in primary health care
centers7. The Turkish Ministry of Health has recommended
that all pregnant women who had not been vaccinated in
childhood, whose vaccination status was unknown, who
have not been fully vaccinated, or who have not received

World Health Organization (2000). Maternal and neonatal tetanus elimination by 2005: Strategies for achieving and maintaining elimination [online].
Website https://www.who.int/vaccines-documents/ [accessed 16.12.2018].
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Table 1. Comparison of the demographic and socioeconomic characteristics between the fully
vaccinated and unvaccinated pregnant women.
Vaccinated
n = 366 (74.1%)

Unvaccinated
n = 128 (25.9%)

P-value

Age

28.49 ± 5.94

29.23 ± 6.11

0.232†

Gestational age at birth

38.13 ± 2.59

37.78 ± 3.16

0.542†

Parite

0.221*

Nullipar (n = 162)

162 (36%)

30 (23.6%)

Multipar (n = 332)

235 (64%)

97 (76.4%)

Illiterate (n = 21)

10 (47.6%)

11 (52.4%)

Primary school (n = 234)

174 (74.4%)

60 (25.6%)

Secondary school (n = 167)

128 (76.6%)

39 (23.4%)

University or higher (n = 72)

54 (75.0%)

18 (25.0%)

Low (n = 274)

196 (71.5%)

78 (28.5%)

Moderate (n = 185)

137 (74.1%)

48 (25.9%)

High (n = 35)

33 (94.3%)

2 (5.7%)

Housewife (n = 406)

300 (82.0%)

106 (28.0%)

Working (n = 88)

66 (75.0 %)

22 (25.0%)

Education

0.311*

Socioeconomic status

0.048*

Occupation

0.829*

Smoking

0.876*

No (n = 438)

325 (65.2%)

113 (34.8%)

Yes (n=56)

41 (53.3%)

15 (46.7%)

*Chi square test; † Independent t test.
Table 2. Characteristics of the antenatal follow-up of the vaccinated and unvaccinated women.
Vaccinated
n = 366 (74.1%)

Unvaccinated
n = 128 (25.9%)

Yes (n = 463)

354 (76.5%)

109 (23.5%)

No (n = 31)

12 (38.7%)

19 (61.3%)

Regular antenatal care

<0.05*

Type of prenatal care facility

<0.05*

Family health center (n = 9)

8 (88.9%)

1 (11.1%)

State hospital (n = 423)

323 (76.4%)

100 (23.6%)

Private practice (n = 32)

22 (68.7%)

10 (31.3%)

University hospital (n = 12)

10 (83.3%)

2 (16.7%)

Absence of prenatal care (n = 18)

3 (16.7%)

15 (83.3%)

Yes (n = 340)

305 (89.7%)

35 (10.3%)

No (n = 154)

61(39.6%)

93(60.4%)

Informed about tetanus vaccine

* Chi square test.
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Table 3. Main reasons for vaccine refusal.
n

%

I did not know I had to be vaccinated

60

46.8

I do not think the vaccine is useful

16

12.5

I did not know where or when to get the vaccine

15

11.7

I was already vaccinated in a previous pregnancy

14

10.9

I did not have time to get the vaccine

11

8.5

My obstetrician did not recommend it

5

3.9

I’m afraid of the needle

3

2.3

I have concerns about the contents of the vaccine

3

2.3

I thought the vaccine would have adverse effects on the baby

1

0.7

a rapel dose in the last 10 years should be administrated
a minimum of 2 doses of Td at 4-week intervals during
pregnancy. Moreover, a total of 5 doses should be given to
all women of reproductive age (15–49 years)8.
From 1999 to March 2019, a reduction of about 96%
in NT-related deaths was observed through the efforts
of the United Nations Children’s Fund, WHO and the
United Nations Population Fund9. Despite all of the
recommendations and practices, according to the WHO
2018 data, 13 countries have still been unable to achieve
MNT elimination10. Overall, the tetanus vaccination rate
in pregnant women has been reported as 72% according to
the WHO November 2018 data10.
In Turkey, MNT elimination targets were achieved in
2009 and this was approved by the WHO. There was only
1 reported NT case in 2014, and there have been no NT
cases reported in the last 5 years in Turkey. According to
the 2019 WHO data, the rate of Td vaccination during
childhood was 96% while the rate was only 55% during
pregnancy in Turkey10. Unfortunately, this rate is far
from the intended rate (80%); hence, it is important to
take the necessary precautions about this problem. It was
demonstrated that the rate of fully vaccinated women was
48.9% in the current study population. This result was
similar to the 46.7% vaccination rate obtained by Maral
et al. in another study conducted in Ankara [5]. These
results showed that the Td vaccination rate was about

50% in women who delivered at tertiary hospitals and
these findings may not reflect the real status of national
vaccination rates. Thus, MT vaccination might be less than
50% in some regions.
According to the WHO recommendations, in a
country where at least 80% of mothers are vaccinated
against tetanus, sterile delivery conditions together
with hygienic cord care may be sufficient to prevent NT.
However, if maternal immunization rates are less than
80%, it is recommended to develop new strategies towards
vaccination programs11. In Nigeria, the Td vaccination rate
was reported to be 62% in 2018. Moreover, 89% of births in
Nigeria occurred under unhygienic conditions without the
aid of skilled healthcare professionals. As a result, 130 NT
cases were reported in Nigeria in 2018, which is 1 of the
13 countries where MNT elimination has not be achieved
[6]. Similarly, in Pakistan, the vaccination rate during 2018
was 60%, and 52% of the births occurred outside hospitals.
Pakistan is also another country where MNT is still an
important issue [7]. According to the Turkish national
data, the birth rate at a health care centers is 97%12. In this
regards, Turkey has shown great success despite the low
Td vaccination rate. However, it would still be beneficial to
increase tetanus vaccination rates to prevent NT.
The WHO data, together with the current findings,
have shown that almost 1 out of every 2 pregnant women
in Turkey has still not been vaccinated against tetanus.
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About 46% of the women who had not been vaccinated in
the current study stated that they did not know that they
should be vaccinated, and the majority of the remaining
cases thought that the vaccine was not useful and they did
not know where or when to get the vaccine exactly. There
were 109 women who answered no to the question “Did
you know that the tetanus-diphtheria vaccine that you got
in your pregnancy would protect your baby against these
bacteria at birth?”. Among them, 87.2% replied “I would
have had the vaccination if I had known”. Unfortunately,
these findings have shown that pregnant women are not
adequately informed about Td vaccine in Turkey. The
main reason for not having enough information is most
probably inadequate antenatal care for these women.
The rate of vaccination in women with regular antenatal
care was 76.5%, whereas only 38.7% of the vaccinated
women did not have sufficient antenatal care. Notably, the
vaccination rate was 89.7% in women who stated that they
had been informed about Td vaccine during pregnancy.
The American College of Obstetricians and
Gynecologists put forth some suggestions for all
obstetricians regarding maternal vaccination. Obstetricians
should know the current vaccine recommendations, inform
their patients, and encourage them to vaccinate in order to
reduce the incidence of vaccine-preventable diseases [8].
The low rates of tetanus vaccination in pregnancy have

been reported to be related with insufficient information
provided by obstetricians13. Controversially, 98.7% of
physicians stated that they had recommended tetanus
vaccine to their patients in another study [9]. Swamy et
al. reported that the rate of vaccination increased if it was
recommended by obstetricians [10]. In the current study,
45.3% of the women who had regular antenatal care stated
that they were informed by their physicians.
Ensuring hygienic conditions at birth and maternal
immunization resulted in MNT elimination in Turkey.
On the other hand, the vaccination rate of at least 80%
(recommended to prevent NT by the WHO) has not
been achieved in Turkey to date. All pregnant women
should be encouraged to get regular antenatal care to
increase vaccination rates. Health care providers should
give detailed information about the safety, effectivity, and
benefits of vaccines to all pregnant women.
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